PSNL 144 SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

PSNL ▼ -5.70% at T+5d

SHORT call ✓ call won +5.70% · α vs SPY +3.18% · entry $11.40 → $10.75

Next anchor: T+20d in 11d

Last close $9.59 (close Jun 12) · +15.88% from $11.40 entry (call sign-flipped)

Entry anchored
May 28, 2026
via day open

T+1d

-1.23%

call +1.23% · α +1.49%

$11.26

settled 17d ago

T+5d

-5.70%

call +5.70% · α +3.18%

$10.75

settled 11d ago

T+20d

—

call — · α —

—

in 11d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Director and Officer Christopher M. Hall filed a Form 144 notice of intent to sell 100,000 shares of Personalis common stock, with an approximate market value of $949,000 based on the filing date. The shares derive from stock option exercises expected over the next three months. While this represents a notable insider sale, it is structured as a planned exercise-and-sell program of options, not a discretionary open-market sale, which slightly reduces the negative signal.

Actionable Insight

A director/officer filing to sell a meaningful but not massive block (~0.1% of market cap) through option-exercise-sales scheduled over three months. This is not an emergency liquidation but may signal the insider's view that current price levels are acceptable to monetize. Monitor for the actual Form 4 filings on execution to see if the pace accelerates. The stock has historically reacted negatively to prior reports on this ticker; context suggests a slight bearish bias near-term.

Key Facts

Filer: Christopher M. Hall (Director and Officer of Personalis, Inc.)
Proposed sale of 100,000 shares of common stock
Estimated aggregate market value: $949,000 (based on ~$9.49/sh at filing)
Shares to be acquired through exercise of stock options over next three months
Filing date: May 28, 2026
Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Market cap of issuer: ~$994M (proposed sale ~0.095% of market cap)

Financial Impact

Proposed sale of 100,000 shares valued at ~$949,000, representing ~0.1% of issuer's market cap.

dilution

Risk Factors

Insider may proceed with full sale over three months, adding supply-side pressure
The structured option exercise program could indicate planned diversification rather than outlook-driven selling, but the intent remains a negative signal
Stock's market cap ~$994M means this sale size is modest but could still weigh on sentiment given ticker's recent poor call performance

Market Snapshot

Exchange

Nasdaq

Sector

Services-Medical Laboratories

Analyst Consensus

85% bullish (13 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

Document	Accession Number
144 Filing (Primary)	0001950047-26-005239
Document: 0001950047-26-005239-index.html	0001950047-26-005239
Document: 0001950047-26-005239.txt	0001950047-26-005239

5 reports for PSNL

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for PSNL — sortable, filterable
	Type				Now
Jun 6, 2026 9d ago	Insider Cluster NEUTRAL ★ 3/10	$11.75 awaiting T+5	awaiting T+5	—	$9.59 (−18.38%)
Jun 4, 2026 10d ago	144 NEUTRAL ★ 3/10	$12.08 awaiting T+5	awaiting T+5	—	$9.59 (−20.61%)
May 30, 2026 16d ago	Insider Cluster BEARISH ★ 5/10	$11.26 $10.75	▲ +4.53%	▲ +1.78%	$9.59 (+14.83%)
May 29, 2026 16d ago	144 NEUTRAL ★ 3/10	$11.26 $10.75	▼ −4.53%	▼ −1.78%	$9.59 (−14.83%)
May 28, 2026 17d ago	144 BEARISH ★ 5/10	$11.40 $10.75	▲ +5.70%	▲ +3.18%	$9.59 (+15.88%)

US Market Status

Market Closed — Opens in 1h 40m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access